We present a general method for estimating the effect of a treatment on an ordinal outcome in randomized trials. The method is robust in that it does not rely on the proportional odds assumption. Our estimator leverages information in prognostic baseline variables, and has all of the following properties: (i) it is consistent; (ii) it is locally efficient; (iii) it is guaranteed to match or improve the precision of the standard, unadjusted estimator. To the best of our knowledge, this is the first estimator of the causal relation between a treatment and an ordinal outcome to satisfy these properties. We demonstrate the estimator in simulations based on resampling from a completed randomized clinical trial of a new treatment for stroke; we show potential gains of up to 39% in relative efficiency compared to the unadjusted estimator. The proposed estimator could be a useful tool for analyzing randomized trials with ordinal outcomes, since existing methods either rely on model assumptions that are untenable in many practical applications, or lack the efficiency properties of the proposed estimator. We provide R code implementing the estimator.
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Introduction
Our methods are motivated by questions that arose in a randomized trial of a new treatment for stroke. This trial is fully described in Section 2, and is summarized here. The outcome is an individual's score on the modified Rankin Scale (mRS), which takes integer values from 0 to 6 representing his/her degree of functional disability. The goal is to estimate the marginal effect of the treatment versus control on this ordinal outcome. We leverage information in prognostic baseline variables to improve precision in estimating the unconditional treatment effect. We propose a new class of estimators for this problem, which can be applied in randomized trials or more generally in observational studies.
In randomized trials with ordinal outcomes, a standard approach is to estimate the marginal treatment effect by assuming the proportional odds model. A downside is that this approach relies on the proportional odds assumption, which may be untenable in many practical applications. To address this, we introduce a nonparametric extension of the parameter in the proportional odds model. This parameter is a summary measure for comparing any pair of ordered, multinomial distributions. It equals the average of the cumulative log odds ratios across categories. We propose an estimator of this parameter that incorporates information in prognostic baseline variables and is guaranteed to be consistent, without requiring parametric model assumptions. Furthermore, this estimator is guaranteed to have greater or equal asymptotic precision than the standard unadjusted estimator; our estimator is also locally semiparametric efficient. The above claims hold under the assumption that outcomes are either all observed, or are missing completely at random as defined in Section 3.2. We also consider other ways that outcomes could be missing, and describe how the estimator adjusts for informative loss to follow-up. [13, 14, 17] laid the foundation for locally efficient estimation of causal effects, which has been extended to incorporate enhanced efficiency properties, e.g., by [19, 24, 28, 21, 5, 20, 15, 8] . Targeted minimum loss based estimation of the effect of treatment on binary, continuous, and time to event outcomes in randomized trials was first discussed in [10] and [18] . We build on the general ideas in [24] and [8] to construct a targeted minimum loss based estimator of the new parameter defined in Section 3.1, which represents the marginal effect of a treatment on an ordinal outcome, without making the proportional odds assumption. Our main contribution is to develop an estimator with variance guaranteed to be smaller or equal than the variance of the unadjusted estimator, asymptotically, for this parameter. Focusing on this goal allows us to develop estimators with computational advantages not available for the estimators of [8] , which were constructed to achieve additional efficiency properties. Specifically, our estimators do not need to solve a non-convex optimization problem, which can be computationally challenging. We demonstrate our estimator in simulations based on resampling from a completed randomized trial, where we show potential efficiency gains of up to 39% compared to the unadjusted estimator.
In Section 2, we describe the MISTIE II randomized trial, which motivated our work. In Section 3, we define our estimation problem and present the nonparametric extension of the proportional odds model along with a corresponding unadjusted estimator. In Sections 4 and 5, we develop a new estimator of this nonparametric extension that is guaranteed to have asymptotic variance smaller or equal to the variance of the unadjusted estimator. We present a simulation study based on data from the MISTIE II trial in Section 6. We discuss directions for future research in Section 7.
size is reduced by 1 − (1/1.34) ≈ 25% when using the adjusted estimator compared to the unadjusted estimator, in order to achieve a given power (e.g. 80% power) at a given alternative, asymptotically. This gives an initial indication that adjusting for baseline variables has potential to improve precision in the context of ordinal outcomes. Below, we present theoretical results and a simulation study comparing our adjusted estimator versus the unadjusted estimator.
Problem Definition

Notation
Let O = (W, A, ∆, ∆Y ) ∼ P 0 denote a random vector with unknown distribution P 0 , where Y denotes an ordinal outcome taking values in {1, . . . , K} observed only when the censoring variable ∆ = 1; A denotes a binary treatment; W denotes a vector of pre-treatment variables. We refer to the distribution P 0 as the observed data distribution, in contrast to the distribution of potential outcomes defined next. Define the potential outcomes Y a : a ∈ {0, 1} to be the outcomes that would have been observed had treatment A = a been assigned with probability one.
We consider randomized trials where all participants are randomly assigned to treatment or control independent of baseline variables W . Therefore, the distribution of A given W is set by design, and so is known. We assume that P 0 ∈ M, where M is the model defined as all continuous densities on (W, A, ∆, ∆Y ) with respect to a common measure ν, such that A is independent of W . The index naught in P 0 denotes the true distribution, and is added to the notation of any quantity whenever it is necessary to avoid confusion, but is omitted otherwise. Denote θ a (k) = P (Y a ≤ k), and θ = (θ a (k) : k = 1, . . . , K − 1; a = 0, 1). Consider the following proportional odds model for ordinal outcomes:
where logit(x) = log{x/(1 − x)}. Setting a = 0 in the above display, it follows that α k = logit θ 0 (k). Therefore, the main assumption of the proportional odds model is that logit θ 1 (k) − logit θ 0 (k) equals a common value β par for all k ≤ K − 1. The proportional odds assumption may be untenable in many practical applications, and it is desirable to use a method that is robust to this assumption being false. To address this, we define a univariate contrast between two ordered, multinomial distributions, using the general approach for constructing nonparametric extensions outlined by [11] . Define the nonparametric extension β(θ) of β par as follows:
The solution to the above minimization problem is
This implies that β(θ) is the average of the cumulative log odds ratios across K − 1 categories. We omit the dependence of β on θ whenever there is no confusion. The parameter β is well-defined without having to assume the proportional odds model; in cases where the proportional odds assumption does hold, the above parameter coincides with the parameter β par of the proportional odds model. An estimator of β is called consistent if it converges to β in probability. We say an estimator of β is locally efficient at P 0 if it achieves the semiparametric efficiency bound in the model M.
The above nonparametric extension of the proportional odds model has two main advantages compared to assuming model (1) . First, the interpretation of β as a contrast between marginal distributions under treatment versus control averaged across categories does not depend on the correct specification of (1). Second, this extension allows construction of estimators of the causal contrast β (and corresponding standard errors) that are consistent regardless of whether assumption (1) holds.
Our goal is to estimate the parameter (24) , which represents an unconditional treatment effect, i.e., a contrast between marginal distributions of the outcome under assignment to treatment versus control. An alternative goal, not considered here, is to estimate a conditional effect of treatment, i.e., a contrast between distributions conditioned on the values of certain baseline variables. Though we do not estimate conditional effects, we do harness information in baseline variables in our estimators of unconditional treatment effects.
Identification of β as a Function of P 0
Under the ignorability assumption Y a ⊥ ⊥(A, ∆)|W for each a ∈ {0, 1}, the positivity assumption P (A = a, ∆ = 1|W ) > 0 with probability 1 for each a ∈ {0, 1}, and the consistency assumption that Y a = Y on the event A = a, the treatment-specific probabilities θ a (k) are identified as a function of P 0 as [see, e.g., 12 ]
for k ∈ {1, . . . , K − 1}, a ∈ {0, 1}, where p(k, a, w) = P 0 (Y ≤ k|∆ = 1, A = a, W = w) and the expectation in (3) is with respect to the marginal distribution of W under P 0 . This implies that under the above assumptions, the parameter β is identified as a function of observed data distribution P 0 of O = (W, A, ∆, ∆Y ), despite the definition of β being in terms of potential outcomes Y a . In a randomized trial, (Y a , W )⊥ ⊥A by design, which we call the randomization assumption. This assumption, combined with the assumption that outcomes are missing at random (i.e., Y a ⊥ ⊥∆|A, W , denoted MAR [16] ), implies the ignorability assumption above. If, in addition, the positivity and consistency assumptions hold, then (3) follows. Throughout, we make the randomization and MAR assumptions.
We define the hazard representation of p(k, a, w) as follows:
where we define h(m, a, w) = P (Y = m|Y ≥ m, ∆ = 1, A = a, W = w), whenever P (Y ≥ m|∆ = 1, A = a, W = w) > 0, and h(m, a, w) = 0 otherwise. It follows that h(0, a, w) = 0 and h(K, a, w) = 1 with probability 1. Under the assumptions in the first sentence of this subsection, we can express θ a (k) in terms of the function h as follows:
where P W is the marginal distribution of W . Substituting (5) into (24) gives an expression for β in terms of the function h, which is identified from the observed data distribution P 0 . We use the notation g A,0 (a|w) = P 0 (A = a|W = w), g ∆,0 (a, w) = P 0 (∆ = 1|A = a, W = w), and g 0 = (g A,0 , g ∆,0 ). The randomization assumption implies g A,0 (a|w) does not depend on w. Since the randomization probability is set by design in our context of a randomized trial, g A,0 is known. However, our adjusted estimators involve fitting a parametric model for g A,0 ; intuitively, this model fit captures chance imbalances of the baseline variables W between arms, for a given data set. The general approach of improving efficiency by estimating known nuisance parameters such as g A,0 has been shown, e.g., by [14] and van der Laan and Robins [22, Theorem 2.3] .
In the remainder of the paper our statistical parameter of interest is β(θ), where θ is defined in terms of h and the marginal distribution of W through (5). Then β(θ) is a function of P 0 , with the caveat that it only has a causal interpretation under the assumptions in the first sentence of this subsection. The estimators of θ a (k) and β developed in Sections 4 and 5 are substitution estimators, that is, estimators constructed from (5) and (24) by replacing h and P W by estimates of these quantities. Substitution estimators have the advantage that they remain within bounds of the parameter space, a characteristic that is particularly desirable in estimation of the multinomial probabilities θ a (k). The goal of this paper is to construct a substitution estimator of β with the properties outlined in the abstract. We start by discussing simpler estimators: the unadjusted estimator and a regression-based estimator.
Unadjusted Estimator
Under the assumption that outcomes are missing completely at random (i.e., (A, ∆)⊥ ⊥(W, Y a ), denoted MCAR), it can be shown that θ a (k) = P (Y ≤ k|∆ = 1, A = a). Then each θ a (k) is consistently estimated by the following unadjusted estimator that ignores baseline variables:
where 1(X) is the indicator variable taking value 1 if X is true and 0 otherwise. Define the vector
The corresponding substitution estimator of β iŝ β unadj = β(θ unadj ). The asymptotic behavior ofβ unadj is obtained through the delta method as
where
is the influence function ofβ unadj . As a consequence,β unadj is asymptotically Gaussian with variance V (Sβ
Under the MCAR assumption, this estimator is consistent and efficient for the case where only (A, ∆, ∆Y ) are observed; however, the unadjusted estimator is generally not efficient for the case where (W, A, ∆, ∆Y ) are observed. Intuitively, this is because the unadjusted estimator fails to leverage prognostic information in baseline variables W . Furthermore, under the less restrictive missing at random (MAR) assumption, the unadjusted estimator will generally not even be consistent, while our proposed estimators are consistent under conditions given in Section 4.
Covariate Adjustment: Regression and Inverse Probability Weighted Estimators
Consider an estimatorp(k, a, W ) for the probability p(k, a, W ), for example, based on fitting an ordered logistic regression model. Under correct specification of that model, the estimator 1 n n i=1p (k, a, W i ) can be shown to be consistent and efficient for θ a (k). However, if that model is misspecified, this regression estimator will generally be inconsistent, even in randomized trials in which an unadjusted, consistent estimator exists [7] . This undesirable property discourages us from using the aforementioned estimator.
As an alternative, an inverse probability weighted (IPW) estimator of θ a (k) is given bŷ
, whereĝ A (a|w) andĝ ∆ (a, w) are estimators of g A and g ∆ , respectively. (An alternative definition of the IPW estimator replaces the denominator in the above display by n). The IPW estimatorβ ipw = β(θ ipw ) is consistent for β if the estimatorsĝ A ,ĝ ∆ are consistent and converge to g A , g ∆ at rate n −1/2 . However, the IPW estimator is generally not locally efficient.
Doubly Robust, Locally Efficient Estimation
We present a locally efficient, doubly robust estimator of θ. The corresponding substitution estimator of β can be shown to satisfy similar properties using the delta method. The efficient influence function for estimating θ a (k) in the model M is given by [see e.g., 2]
where, for conciseness, we suppress the dependence of D ak on g and p in our notation. The function D ak has two important properties for estimation of θ a (k). First, it is a doubly robust estimating function, i.e., for given estimatorsp,ĝ of p and g = (g A , g ∆ ), respectively, the estimator of θ a (k) formed by solving for θ a (k) in the following estimating equation:
is consistent if at least one of p or g is estimated consistently at sufficient rate, as described below. This double robustness property is desirable since it guarantees that improper adjustment for covariates through a misspecified working model for p does not cause asymptotic bias in the estimator in randomized trials if outcomes satisfy MCAR, or more generally if outcomes satisfy MAR and g ∆ is consistently estimated at a sufficient rate. Second, the efficient influence function characterizes the efficiency bound for estimation of θ a (k) in the model M [3] . Specifically, under consistent estimation of p and g at sufficient rate, the estimatorθ a (k) that solves the estimating equation (9) has variance smaller or equal to that of any regular, asymptotically linear estimator of θ a (k) in M. If we also assume MCAR, then under consistent estimation of p and g at sufficient rate, the corresponding substitution estimator β(θ) is equal or superior toβ unadj in terms of asymptotic precision. Various estimators using D ak have been proposed in the context of a binary outcome, including the augmented inverse probability weighted estimator, the doubly robust weighted least squares estimator, and the targeted maximum likelihood estimator [see 2, 9, for a review]. In principle, those methods may be used to estimate the multinomial probabilities θ a (k) by considering K binary outcomes 1{Y ≤ k} : k = 1, . . . , K separately. This approach, however, does not guarantee that the resulting estimates yield a well defined multinomial distribution, i.e., there is no guarantee that the estimate of θ a (k) will be less than or equal to the estimate of θ a (k + 1) for all k.
We next express the efficient influence function (8) in terms of the hazard functions h. Define I(k) = 1{Y = k} andĪ(k) = 1{Y ≥ k}. Intuitively,Ī(k) is an indicator of being at risk for having Y = k, given only the information I(1), . . . , I(k − 1). The following is proved in Appendix 1:
and p is defined as a function of h in (4).
We now describe a doubly robust, substitution estimator of θ, using targeted minimum loss based estimation (TMLE).
Targeted Minimum Loss Based Estimator It will be convenient to sometimes use a modified data set in which only observations O i with ∆ i = 1 are included, and each such observation O i is repeated for each j = 1, . . . , K − 1 with the indicators I i (j) = 1{Y i = j} andĪ i (j) = 1{Y i ≥ j} replacing Y i as the outcome, i.e., the following data set:
This data set is referred to as the long form, and the original data set is referred to as the short form. An observation in the long form data set is a vector of the form (j,
A TMLE for θ may be computed through the following iterative procedure:
Step 1. Initial estimators. Obtain initial estimatorsĝ A ,ĝ ∆ , andĥ of g A , g ∆ , and h, respectively.
Initial estimator of h. To estimate h we use an approach borrowed from the survival analysis literature: we pool the data and smooth across categories. An estimatorĥ may be obtained by running a prediction algorithm of I(j) as a function of A, W , and j among observations withĪ(j) = 1 in the long form data set (12).
Initial estimators of g A and g ∆ . We estimate g A by fitting a parametric model for the probability of {A = 1} as a function of W in the short form data set. We estimate g ∆ analogously. In a randomized trial, g A is set by design; however, it can still improve efficiency of the TMLE to estimate g A using, e.g., the proportion of individuals in the treatment group, or a parametric model that contains baseline variables and an intercept. In general, the functional relation between ∆ and (A, W ) is unknown to the researcher; one may apply flexible prediction techniques such as model stacking [27] or super learning [25] to estimate g ∆ .
Step 2. Iteratively update estimate of h by maximum likelihood in least favorable parametric model. Initialize l = 0, and letĥ l =ĥ. In the long form data set, for each observation, augment it with 2(K − 1) covariates Z l ak (j, A, W ) : k = 1, . . . , K − 1; a = 0, 1 by substituting the estimatesĥ l andĝ in (11) . This augmented long form data set is defined as
Estimate the parameter vector = { ak : k = 1, . . . , K − 1; a = 0, 1} in the logistic hazard submodel for h(j, a, w):
by computing the following maximum likelihood estimator:
The maximizerˆ can be computed using standard statistical software by a logistic regression of I(j) on the 2(K − 1) variables {Z l ak (j, A, W ) : k = 1, . . . , K − 1; a = 0, 1} among observations withĪ(j) = 1 in the augmented long form data set (13) , and using logitĥ l (j, a, w) as an offset.
Since the gradient of the expression on right side of (15) is 0 at the maximizer , it follows thatĥ l+1 solves the estimating equations
for each k = 1, . . . , K − 1, a = 0, 1.
Step 3. Iterate. Update l = l + 1 and iterate Step 2 until convergence. We use
as a stopping criterion.
Letĥ denoteĥ l corresponding to the final iteration l of the above procedure. Define the TMLE of θ a (k) asθ
Analogously, define the TMLE of β asβ adj = β(θ adj ). This is a substitution estimator, i.e., it is the result of substituting estimates of h and P W into the parameter definitions (5) and (24) . It follows from (16), (17) , and the representation of D ak in (10) , that the efficient influence function estimating equation is approximately solved at the last iteration, i.e.,
whereD ak is obtained by substitutingĝ A ,ĝ ∆ , andĥ into (10) and (11) .
First, consider the case whereĥ andĝ converge to h and g, respectively, each at rate faster than n −1/4 . It follows from the general arguments in van der Laan and Rose [23, Appendix 18] that
which implies thatθ adj,a (k) is efficient in the semiparametric model M. The delta method implies
is the efficient influence function for estimation of β in M. In this case, if we additionally assume MCAR, local efficiency ofβ adj implies thatβ adj has asymptotic variance smaller or equal to the asymptotic variance ofβ unadj . Second, consider the case whereĥ does not converge to h (which could occur if the model for h is misspecified) but does converge to some limit, and g is estimated consistently at rate n −1/2 (which holds in our context of a randomized trial if g A , g ∆ are estimated using parametric models that include intercepts, and if either (i) outcomes satisfy MCAR or (ii) outcomes satisfy MAR and the parametric model for g ∆ is correct). Thenβ adj is consistent. However, in this case and under MCAR, there is no guarantee that the asymptotic variance ofβ adj is at most that ofβ unadj . In the next section we present a substitution estimator of β that has this guarantee.
Guaranteed Equal or Better Asymptotic Efficiency Compared to the Unadjusted Estimator
We develop an adjusted estimator, denotedβ adj,eff , that is guaranteed to be consistent and to have asymptotic variance smaller or equal to the asymptotic variance ofβ unadj , under MCAR and if the initial estimator for g is based on parametric models that include intercept terms. The corresponding estimator β adj,eff provides protection against biased estimates of h, allowing researchers to safely adjust for covariates in the analysis of a randomized trial, with the goal of improving precision for estimating β, under MCAR. Additionally, this estimator has the same double robustness and local efficiency properties as the estimator in the previous section. In particular, if the outcome is MAR and the parametric model used to estimate g ∆ is correctly specified, then the convergence ofβ adj,eff to β still holds whereasβ unadj will generally be inconsistent. The only difference between the TMLE algorithm forβ adj in the previous section and the TMLE algorithm forβ adj,eff below is that the latter updates the estimatorsĝ A andĝ ∆ at each iteration. This is done by fitting logistic regression models for the expectation of A and ∆ conditional on auxiliary variables that are functions of the following:
The TMLE algorithm forβ adj,eff is given below:
Step 1. Initial estimators. Obtain initial estimatorsĝ A ,ĝ ∆ , andĥ of g A , g ∆ , and h, respectively. This may be done as described in the previous section.
Step 2. Iteratively update estimates of h and g. Initialize l = 0, and letĥ
(a) Updateĥ l . This is the same as step 2 in the TMLE algorithm from Section 4, except using the current updates of the estimators of g at each iteration, rather than always using the initial estimators of g. Augment each observation in the long form data set (12) by 2(K − 1) covariates Z (11) . Estimate byˆ in the logistic hazard submodel (14) by maximum likelihood estimation as in (15) .
l and the empirical distribution of W substituted for h and P W , respectively, in (5) 
substituted for the corresponding components in (19) . In the short form data set, compute the auxiliary covariate
Estimate the parameter ν in the following logistic regression submodel for g A (1|w):
by regressing A on W among all participants i = 1, . . . , n using a logistic regression model with single covariate M l (W ) and offset logitĝ l A (1|W ); denote the corresponding maximum likelihood estimate of ν byν. (19) . In the short form data set, compute the auxiliary covariate
Estimate the parameter γ in the following logistic regression submodel for g ∆ (a, w):
by regressing ∆ on A, W among all participants i = 1, . . . , n using a logistic regression model with single covariate H l (A, W ) and offset logitĝ l ∆ (A, W ); denote the corresponding maximum likelihood estimate of γ byγ.
Step 3. Update l = l + 1 and iterate the previous step until convergence. Analogous to the TMLE algorithm in Section 4, we stop at the first iteration for which the mean of the squared difference of predictions between step l and step l + 1 is smaller or equal to 10 −4 /n, but this time adding the requirement that this holds forĝ Denoteĥ ,ĝ A , andĝ ∆ the estimators obtained in the last iteration of the above algorithm, and define the corresponding TMLE estimator of θ a (k) aŝ
and the corresponding estimatorβ adj,eff = β(θ adj,eff ). Next, we present the main result of the paper giving conditions under whichβ adj,eff is guaranteed to be at least as efficient asβ unadj = β(θ unadj ).
Theorem 2 (Guaranteed equal or greater asymptotic efficiency ofβ adj,eff compared toβ unadj ). Assume that MCAR and the randomization assumption hold. Assume also thatĥ,ĝ A , andĝ ∆ are estimated using maximum likelihood estimation in parametric models containing at least an intercept term. Under the additional assumption that the empirical means of the estimated efficient influence functions S(O) and Sβ
where σ 2 adj,eff ≤ σ 2 unadj . In addition, ifĥ converges to h in L 2 (P 0 ), thenβ adj,eff achieves the efficiency bound in the semiparametric model M.
A sketch of the proof along with the technical conditions is provided in Appendix 2. By construction of the TMLE algorithm, it is expected that the empirical mean of the estimated efficient influence function will converge to zero, thereby satisfying the assumptions of the theorem. Our simulated distributions are based on resampling data from the completed MISTIE II trial described in Section 2. This was done in order to make our simulations realistic, in that they mimic key features of a real trial. We compare the performance of the unadjusted, IPW, and proposed targeted minimum loss based estimatorβ adj,eff (referred to as TMLE below). The baseline variables for each participant are W = (W 1 , W 2 , W 3 ) = (age, ICH volume, NIHSS) and we assume there is no missing data; i.e., ∆ = 1 for all subjects. Below, we refer to β as the treatment effect. Simulations are conducted under the following four different types of data generating distributions (called scenarios):
(i) Y and W dependent; zero treatment effect (β = 0).
(ii) Y and W dependent; positive treatment effect (β > 0).
(iii) Y and W independent; zero treatment effect (β = 0).
(iv) Y and W independent; positive treatment effect (β > 0).
In scenarios (i) and (iii), we set β = 0 and in scenarios (ii) and (iv), the simulated data is generated to replicate the estimated treatment effect reported in the MISTIE II trial, which is 0.252 (which equals the unadjusted estimator directly applied to the trial data). In scenarios (i) and (ii), W is prognostic for Y , and there is potential for efficiency gains from adjusting for W . In scenarios (iii) and (iv), baseline variables are not prognostic for the outcome; we consider these scenarios in order to examine how much efficiency loss occurs for the adjusted estimators when the baseline variables are pure noise.
For each scenario, we generated 100,000 simulated randomized trials, each with n = 412 participants. This sample size was selected to mimic the projected size of the planned Phase III trial that is a follow-up to the MISTIE II trial.
The primary outcome, mRS at 180 days after enrollment, is ordinal and takes integer values from 0 to 6, with 0 representing no disability and 6 representing death. In the Phase II MISTIE trial, the primary outcome was always at least 1 and only one subject had mRS = 1. We combined the values 0,1,2 into a single category in our analysis, denoted by 0-2.
Each simulated randomized trial is based on resampling triples (W, A, Y ) with replacement from the MISTIE II trial data, followed by modifications described below. These modifications were necessary since directly resampling with replacement corresponds to the empirical distribution from the MISTIE II trial, and in this data set the variables A and W have small, non-zero correlations. Therefore, directly resampling would correspond to a data generating distribution P 0 in which A and W are dependent, which violates the randomization assumption from Section 3.2 that under P 0 , the study arm A is assigned independent of W . We next describe modifications to the empirical distribution of the MISTIE II data that ensure the randomization assumption holds for the data generating distributions in our simulations.
For scenarios (i) and (ii), we resampled pairs (W, Y ) with replacement from the MISTIE II trial data. This preserves the correlations between baseline variables and the outcome. In scenario (i), we generated A independent of (W, Y ), with probability 1/2 of being treatment or control. The resulting treatment effect for this data generating distribution is β = 0.
Each simulated data set in scenario (ii) consists of first generating an initial data set as in scenario (i), and then reassigning a subset of the outcome values using the algorithm described next. In order to induce a treatment effect that mimics the effect from the MISTIE II trial (β = 0.252), for each participant in the initial data set with A = 1 we randomly reassign the individual's outcome with probability that is a pre-computed function q(Y ) of his/her initial value of Y . If an individual's outcome is reassigned, it is replaced with a randomly generated outcome according to a pre-computed multinomial distribution. This procedure is done for each participant independent of the other participants. The pre-computed distributions, which were constructed to mimic features in the MISTIE II data, are given in Appendix 3.
For scenarios (iii) and (iv), baseline variables W for each participant were randomly drawn with replacement from the MISTIE II trial data. This results in the marginal distribution of W being the empirical distribution of the MISTIE II trial data. Study arm assignment A was generated independent of W , with probability 1/2 of being treatment or control. In scenario (iii), Y is a random draw from a multinomial distribution with probabilities 0.12, 0.20, 0.27, 0.16, 0.25 for mRS of 0-2, 3, 4, 5, 6, respectively (which equal the corresponding empirical probabilities when pooling all participants in MISTIE II). Since A is generated independent of (W, Y ), this results in β = 0. In scenario (iv), the conditional distribution of Y given A = a and W is set to be a multinomial distribution with probabilities 0.11, 0.14, 0.32, 0.16, 0.27 and 0.12, 0.24, 0.24, 0.16, 0.24, respectively for a = 0, 1, which correspond to the empirical probabilities in each arm in MISTIE II.
Logistic regression models are used to estimate g A in the IPW estimator, and are used in the initial estimators in step 1 of the TMLE for both g A and h. The logistic regression model for g A includes an intercept and a main term for each component of W . Since treatment is randomized in all scenarios, we have P (A = 1|W ) = 1/2, which implies the model for g A is correctly specified. The logistic regression model for h includes intercepts for the first K − 1 levels of Y , main terms W and A, and interaction terms for the K − 1 intercepts with A and W .
In scenarios (i) and (ii), the simulation distribution of Y given A, W includes correlation between Y and W based on resampling from the MISTIE data; therefore, non-saturated parametric models for h such as those used in the TMLE estimator will generally be misspecified. We intentionally generate data in this way, to mimic the realistic feature that h will be at least somewhat misspecified in practice. In contrast, for scenarios (iii) and (iv), since Y and W are independent, the parametric model for h above is correctly specified.
Simulation Results
The results of the simulation are presented in Table 1 . In all scenarios, each estimator has very small bias. In scenarios (i) and (ii), there are large gains in efficiency for both the IPW estimator and TMLE relative to the unadjusted estimator. These gains are due to the strong correlation between W and Y . The gains in efficiency are 4% greater for the TMLE relative to the IPW estimator. In scenarios (iii) and (iv), where W is not prognostic for Y , there are efficiency losses between 0.7% and 0.9% from using the adjusted estimators. 
Discussion
The method we present may be extended to other cases. In particular, observational data (where A and W are generally dependent) may be handled using the estimatorβ adj , under the ignorability assumption from Section 3.2. Under certain regularity conditions,β adj is a doubly robust, locally efficient estimator of β, which identifies the causal effect. We conjectureβ adj,eff has asymptotic variance smaller or equal than an inverse probability weighted estimator computed with g 0 known, under stronger assumptions that include consistent estimation of g 0 at an appropriate rate, and other regularity conditions. In addition, the natural formulation of the problem in terms of hazard functions allows the straightforward use of the methods to handle discrete time-to-event outcomes with no time varying covariates. This is done by considering a categorical outcome taking values in an ordered set of discrete time points {1, . . . , τ }. In this case, our parameter defines a contrast between the two survival functions, and our method can be applied to estimate this parameter as well as the survival functions after accounting for baseline covariates. The method we describe may be generalized to estimate other parameters of interest relevant to time-to-event outcomes such as the relative hazard. 
Note that
This yields
.
and the result follows.
A.2 Sketch of Proof for Theorem 2
In this section we use the notation P f to refer to f (o)dP (o), for a given function f of the data. We also add an index naught to the notation to represent true quantities (e.g., g A,0 ), and use no index to denote generic quantities (e.g., g A ). In addition, we augment the notation of the paper by explicitly including the dependence on the influence functions D ak , D ak , and S on P . Thus,
Define the following two quantities:
Assumptions in the theorem:
1. Randomization assumption and missing completely at random assumption (defined in Sections 3.2 and 3.3).
2. The following assumption:
Intuitively, we expect that the above assumption will hold in many cases, due to the construction of the TMLE. This is because the efficient influence function S may be decomposed as Sβ
where φ is defined above. The TMLE is constructed to solve the estimating equations associated with S and with φ. As a result, the estimating equation associated with Sβ unadj is also solved and the above assumption may be expected to hold.
3. Consistency of initial estimators of outcome hazard. (This assumption is only used for the claim in the last sentence of the theorem.)
P 0 (ĥ − h) 2 = o P (1).
Lemmas:
1. Consistency of initial estimators of treatment/missingness. Under assumption (1) we have
This follows since assumption (1) implies that the parametric models used for g A and g ∆ are correctly specified. Applying the delta method and the continuous mapping theorem, we have that √ nP (ĝ A (a, w) − g A (a, w)) = O P (1), andĝ A (a, w) − g A (a, w) = o P (1), for any fixed a and w. This, together with O P (1)o P (1) = o P (1) and the continuous mapping theorem proves the lemma.
2. Asymptotic linearity of smooth functional of g. Assume P 0 (φ(p 0 ,ĝ ) − φ(p 0 , g 0 )) = (P n − P 0 )S † + o P (1/ √ n),
for some function S † of O. This is a direct consequence of the asymptotic linearity of the MLE in a parametric model and the delta method.
A.3 Data Generating Distribution for Simulation Scenario (ii)
In Section 6.1 of the main paper, it was stated that each simulated data set in scenario (ii) consists of first generating an initial data set as in scenario (i), and then reassigning a subset of the outcome values. Specifically, for each participant in the initial data set with A = 1 we randomly reassign the individual's outcome with probability that is a pre-computed function q(Y ) of his/her initial value of Y . We set q(Y ) = 0, 0, 0.44, 0.06, 0.10 for Y in categories 0-2, 3, 4, 5, 6, respectively. If an individual's outcome is reassigned, it is replaced with a randomly generated outcome according to the pre-computed multinomial distribution, denoted m, on the same set of categories, with probabilities 0.10, 0.90, 0, 0, 0 for the categories 0-2, 3, 4, 5, 6, respectively.
The above values were selected in order that the simulated distribution in scenario (ii) has β = 0.252, which is the estimated treatment effect (unadjusted) in the MISTIE II trial. The above values were obtained by working backward from β to θ a (k), as we describe next. Recall that
We select q and m in order that the resulting simulation distribution has
equal to the corresponding values where each θ a (k) is replaced by the unadjusted estimator of that quantity in the MISTIE II trial. For categories 0-2, 3, 4, 5, the corresponding value of (25) is set to 0.129, 0.575, 0.159, 0.146. This implies β(θ) = (0.129 + 0.575 + 0.159 + 0.146)/4 = 0.252. Since the distribution of Y |A = 0, W is already determined (see the construction of the data generating mechanism for scenario (i)), we can compute θ 0 (k), and then compute θ 1 (k) using the aforementioned values of (25) . We then experimented with values of q and m that produce precisely the aforementioned values of θ a (k). Reproducing such values of θ a (k) mimics the heterogenous log odds ratios across categories in the MISTIE II trial.
